Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026)
Zai Lab (ZLAB) posted quarterly Other Non-Current Assets of $3.2 million for Q1 2026, up 25.02% year-on-year from $2.5 million in Q1 2025, and up 3.73% on a QoQ basis from $3.1 million in Q4 2025.
Zai Lab (ZLAB) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Other Non-Current Assets for 11 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets rose 25.02% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 25.02% YoY) and the FY2025 annual result came in at $3.1 million, down 47.05% from the prior year.
- Other Non-Current Assets advanced to $3.2 million in Q1 2026 per ZLAB's latest filing, from $3.1 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for ZLAB reached as high as $5.8 million in Q4 2024 and fell as low as $803000.0 in Q1 2022.
- A 5-year average of $2.0 million and a median of $1.5 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 377.09% — and 2025, when it plunged 47.05%.
- Year by year, Other Non-Current Assets stood at $1.4 million in 2022, then decreased by 13.4% to $1.2 million in 2023, then jumped by 377.09% to $5.8 million in 2024, then tumbled by 47.05% to $3.1 million in 2025, then increased by 3.73% to $3.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $3.2 million, $3.1 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 803,000.00 |
| Jun 30, 2022 | 803,000.00 |
| Mar 31, 2022 | 803,000.00 |
| Dec 31, 2021 | 803,000.00 |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 743,000.00 |